13 OCTOBER 2025
Automatic Oxygen Treatment - WHITE PAPER
Lesezeit: Min.
Author: Rosa Sammartano

O2matic: smarter oxygen therapy for better patient outcomes
A July 2025 White Paper reveals that the O2matic automated oxygen system significantly outperforms traditional manual oxygen therapy, leading to improved patient safety and comfort.
Manual oxygen adjustments often fail to keep a patient's blood oxygen saturation within the recommended safe range, which can lead to dangerous complications from too little (hypoxemia) or too much oxygen (hyperoxia). In a cross-over study with O2matic, it was showed that manual methods were only effective 47% of the time.
The O2matic device solves this by automatically adjusting oxygen flow every second, ensuring patients remain stable.
Key proven benefits:
- Superior Accuracy: Keeps patients in the target SpO2 range over 85% of the time;
- Reduced Risk: Decreases time spent in dangerous hypoxemia and hyperoxia by more than 50%;
- Greater Comfort: Alleviates shortness of breath for hospitalized COPD patients;
- Increased Mobility: Has been shown to double the walking distance for patients with severe COPD on long-term oxygen therapy.
This advanced therapy also points to economic advantages, such as potentially shorter hospital stays and faster weaning from oxygen supplementation
Right now, Vivisol is investing in the promotion of HOT100 - the O2matic device for home use - in Pescara, Italy, for an innovative titration purpose.
The device is being used as a system to evaluate the needed oxygen consumption of patients in different scenarios, directly from their homes.
The initial results of this project have been very promising. This approach allows patients in rural areas to receive new, more accurate oxygen prescriptions without the logistical challenges and financial burdens of traveling to a clinic.
It's a great stepforward in making our services more accessible and improving the quality of patient care!